Gastrointestinal Function
Conditions
Brief summary
This study aims to evaluate the effect of four high-activity compound probiotic freeze-dried powders on improving gastrointestinal function, observing their regulatory effects on the gut microbiota and the incidence of adverse reactions in study participants over a 4-week intervention period.
Interventions
DIETARY_SUPPLEMENTProbiotic
Probiotic strips with different strain formulas, specification: 3g/bag. Storage method: Keep away from light, seal tightly, and store in a cool, dry place.
Sponsors
Wecare Probiotics Co., Ltd.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
1. Voluntarily, in writing, sign the informed consent form, agreeing to participate in this study 2. Able to complete the study according to the requirements of the trial protocol 3. Age between 18 and 65 years old 4. Meet the diagnostic criteria for gastrointestinal dysfunction established in the Chinese Precision Health Communication Expert Consensus on Citizen's Guide to Gastrointestinal Health 5. Symptoms: Irregular bowel movements, loose or hard stools, abdominal bloating, belching, flatulence, severe intestinal gas, abdominal pain, acid reflux, heartburn, pain in the stomach or abdomen when hungry, nausea 6. Signs: Abdominal pain and bloating, diarrhea and constipation, indigestion, gastric acid reflux, bad breath and foul-smelling flatulence, skin problems, changes in stool color and shape -
Exclusion criteria
1. Use of drugs affecting the intestinal flora (including antimicrobials, probiotics, intestinal mucosal protective agents, traditional Chinese patent medicines, etc.) for more than 1 week continuously within 1 month prior to screening 2. Short-term consumption of products similar to the test substance, which affects the judgment of the results 3. Use of antibiotics during illness 4. Participants with severe systemic diseases or malignant tumors 5. Participants allergic to any components of the compound probiotic freeze-dried powder used in this trial 6. Women who are pregnant or breastfeeding, or those who have plans to conceive in the near future 7. Participants who cannot participate in the trial due to personal reasons 8. Other participants deemed unsuitable for participation by the researcher -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement of gastrointestinal function in study participants | 4 weeks | Bowel movement frequency improvement: use the bowel movement frequency scale to record the number of bowel movements per week for participants, in order to assess changes in bowel movement frequency. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Concentration of Short-Chain Fatty Acids in Fecal Samples | 4 weeks | The concentration of short-chain fatty acids in fecal samples was determined by gas chromatography-mass spectrometry (GC-MS). |
| Metabolite Profile in Fecal Samples as an Indicator of Intestinal Microbiota Health | 4 weeks | The metabolites in fecal samples were detected by liquid chromatography-mass spectrometry (LC-MS). |
Countries
China
Outcome results
None listed